# Clustering Approach 5 : MIRSEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0026554340140128	Range of duration = 0.03 to 158.83, nDeath = 5, nCensor = 221
2	AGE	ANOVA	1.25940734723608e-05	Range of values = 18 to 89, Mean = 46.9035, StdDev = 14.8629
3	GENDER	Fisher's exact test	0.440418990500324	nTypes = 2 (FEMALE/MALE), nPatients = 168/60
4	HISTOLOGICAL.TYPE	Chi-square test	0.00406704924804323	nTypes = 4 (OTHER  SPECIFY/THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL/THYROID PAPILLARY CARCINOMA - FOLLICULAR (>= 99% FOLLICULAR PATTERNED)/THYROID PAPILLARY CARCINOMA - TALL CELL (>= 50% TALL CELL FEATURES)), nPatients = 3/183/16/26
5	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.503237934046723	nTypes = 2 (NO/YES), nPatients = 11/217
6	RADIATIONEXPOSURE	Fisher's exact test	0.999999999999891	nTypes = 2 (NO/YES), nPatients = 196/8, nMissing = 24
7	DISTANT.METASTASIS	Chi-square test	0.00676956128758808	nTypes = 3 (M0/M1/MX), nPatients = 131/4/93
8	EXTRATHYROIDAL.EXTENSION	Chi-square test	0.00114968169334075	nTypes = 3 (MINIMAL (T3)/MODERATE/ADVANCED (T4A)/NONE), nPatients = 75/9/139, nMissing = 5
9	LYMPH.NODE.METASTASIS	Chi-square test	0.587759967999948	nTypes = 5 (N0/N1/N1A/N1B/NX), nPatients = 92/27/55/33/21
10	COMPLETENESS.OF.RESECTION	Chi-square test	0.00635927902262467	nTypes = 4 (R0/R1/R2/RX), nPatients = 181/22/1/13, nMissing = 11
11	NUMBER.OF.LYMPH.NODES	ANOVA	0.216273200405665	Range of values = 0 to 40, Mean = 3.51872, StdDev = 5.62764, nMissing = 41
12	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 228
13	NEOPLASM.DISEASESTAGE	Chi-square test	0.0439283365618196	nTypes = 5 (STAGE I/STAGE II/STAGE III/STAGE IVA/STAGE IVC), nPatients = 131/16/55/22/3, nMissing = 1
14	MULTIFOCALITY	Fisher's exact test	0.264932500892913	nTypes = 2 (MULTIFOCAL/UNIFOCAL), nPatients = 104/121, nMissing = 3
15	TUMOR.SIZE	ANOVA	0.985773778893465	Range of values = 0.3 to 8.2, Mean = 2.82595, StdDev = 1.60694, nMissing = 43